NYSE-listed Stryker, a provider of MedTech products and services, is acquiring Switzerland-based ZuriMED, a privately held company and developer of the FiberLocker System - technology that provides a novel approach for rotator cuff augmentation with increased biomechanical strength to address a key clinical failure mode in rotator cuff repair.
The acquisition...
France-based global healthcare investor, Archimed, has closed its MED IV fund at the €1.5bn (US$1.75bn) hard cap. MED IV, launched in January 2026 with an original target of €1.2bn, was three times oversubscribed, and follows on from the €650m MED III fund. It will pursue the series’ smallcap healthcare buyout strategy, building a diversified, global portfolio.
"The momentum behind MED IV reflects investors' confidence in our approach,” says Denis Ribon, chairman and managing partner at Archimed.
The fund attracted a broad group of existing and current investors - largely institutional limited...